Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Titan Pharmaceuticals Inc (TTNP)  
$0.44 0.00 (0.00%) as of 4:30 Mon 1/8


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 9,860,000
Market Cap: 4.34(M)
Last Volume: 343,990 Avg Vol: 274,696
52 Week Range: $0.258 - $0.76
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 2,283,690
Total Buy Value $0 $0 $0 $1,979,170
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 5
Total Shares Sold 0 0 3,747,968 3,747,968
Total Sell Value $0 $0 $4,610,000 $4,610,000
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 2 2
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 131
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bucalo Louis R Md President and CEO   •       •      –    2007-05-03 4 B $2.38 $19,111 D/D 8,000 508,000 2.81     -
   Farrell Robert Edward Exec Vice President and CFO   •       –      –    2007-04-27 4 B $2.14 $33,170 D/D 15,500 111,580 2.74     -
   Farrell Robert Edward Exec Vice President and CFO   •       –      –    2007-03-20 4 B $2.29 $61,837 D/D 26,000 96,080 2.74     -
   Weis Konrad M Phd Director   –       •      –    2006-03-10 4 OE $1.71 $39,544 D/D 23,125 58,699     -
   Allen Richard C officerTitle   •       –      –    2005-12-06 4 S $1.30 $60,904 D/D (46,488) 0     -
   Allen Richard C officerTitle   •       –      –    2005-12-05 4 S $1.39 $21,356 D/D (15,000) 46,488     -
   Allen Richard C officerTitle   •       –      –    2005-12-02 4 S $1.41 $28,611 D/D (20,000) 61,488     -
   Allen Richard C officerTitle   •       –      –    2005-12-01 4 S $1.44 $10,156 D/D (6,800) 81,488     -
   Bhonsle Sunil EVP and COO   •       •      –    2005-11-07 4 B $1.40 $43,000 D/D 30,000 59,400 2.81     -
   Bhonsle Sunil EVP & COO   •       •      –    2005-11-03 4/A B $1.52 $15,048 D/D 9,900 29,400 2.81     -
   Bhonsle Sunil EVP and COO   •       •      –    2005-11-03 4 B $1.52 $15,048 D/D 9,900 90,294 2.81     -
   Bucalo Louis R Md President & CEO   •       •      –    2005-11-01 4 B $1.66 $5,859 D/D 3,514 500,000 2.81     -
   Huckel Hubert E Md Director   –       •      –    2005-10-24 4 B $1.68 $44,339 D/D 25,700 62,200 2.39     -
   Farrell Robert Edward Executive VP and CFO   •       –      –    2005-10-17 4 B $1.70 $13,940 D/D 8,200 71,780 2.74     -
   Farrell Robert Edward Executive VP and CFO   •       –      –    2005-10-14 4 B $1.68 $168 D/D 100 63,580 2.66     -
   Farrell Robert Edward Executive VP and CFO   •       –      –    2005-10-13 4 B $1.64 $25,897 D/D 15,700 63,480 2.74     -
   Bucalo Louis R Md Pres. & Chief Exec. Officer   •       •      –    2005-10-06 4 B $1.69 $105,392 D/D 62,000 496,486 2.81     -
   Allen Richard C Executive Vice President   •       –      –    2005-10-03 4 OE $1.35 $78,173 D/D 57,906 88,288     -
   Bhonsle Sunil EVP and COO   •       •      –    2005-08-16 4/A B $2.20 $5,500 D/D 2,500 19,500 2.81     -
   Allen Richard C Executive Vice President   •       –      –    2005-01-05 4 OE $0.08 $2,049 D/D 25,617 30,382     -
   Bucalo Louis R Md President and CEO   •       •      –    2004-08-16 4 B $2.20 $5,500 D/D 2,500 434,486 2.81     -
   Bhonsle Sunil Executive VP and COO   •       •      –    2004-08-16 4 B $2.20 $5,500 D/D 2,500 180,394 2.81     -
   Bauer Victor J Phd Director   –       •      –    2004-08-16 4 S $2.20 $11,000 D/D (5,000) 8,644     -
   Bucalo Louis R Md President and CEO   •       •      –    2004-02-09 4 OE $0.59 $48,235 D/D 81,755 431,986     -
   Weis Konrad M Phd Director   –       •      –    2003-11-26 4 OE $0.59 $2,999 D/D 5,117 35,574     -

  131 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed